Image

Patient Centered Mobile Health Technology Enabled Atrial Fibrillation Management

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The overall objective of this proposal is to evaluate the feasibility of a comprehensive digital atrial fibrillation (AFib) management tool that will empower patients to a) take an active role in learning about AFib management options, starting and adhering to evidence-based therapies and lifestyle changes and b) to guide the patients during AFib episodes which are associated with anxiety and impairment in quality of life.

Researchers plan to evaluate the feasibility and preliminary efficacy of this novel digital toolkit in improving quality of life and decreasing AFib burden in a pilot randomized clinical trial (RCT).

Eligibility

Inclusion Criteria

  • 18 years or older
  • Non- valvular Paroxysmal Atrial Fibrillation diagnosed not more than 12 months prior to randomization

Exclusion Criteria

  • Non-English speaking
  • Has previously been evaluated by a cardiologist or electrophysiologist
  • Mitral Stenosis
  • Presence of Artificial Heart Valve
  • Severe valvular disease (any)
  • Physical disability that would preclude technology use, safe and adequate exercise performance
  • Hearing or Visual Impairment that would preclude technology use
  • History of fall one or more times in the last year
  • Hypertrophic obstructive cardiomyopathy with peak resting left ventricular outflow gradient of >25 mmHg
  • Known aortic dissection
  • Severe resting arterial hypertension (SBP >200 mmHg or diastolic BP >110mmHg) upon enrollment (obtained during clinic visit)
  • Mental impairment leading to inability to cooperate with study procedures
  • Untreated high degree atrioventricular block
  • Atrial fibrillation with rapid ventricular rate (Resting heart rate at enrollment visit >110) upon enrollment (obtained during clinic visit)
  • History of cardiac arrest, sudden death
  • MI or cardiac surgery complications of cardiogenic shock and/or congestive heart failure (CHF) and/or signs/symptoms of post-procedure ischemia
  • Left ventricular ejection fraction <40%
  • Clinically significant depression
  • Presence of implanted cardiac device
  • Incomplete revascularization procedure
  • Pregnancy
  • Previous open-heart surgery
  • Unsafe to participate in the program as per treating clinician

Study details

Atrial Fibrillation, Behavior

NCT05400837

Johns Hopkins University

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.